GSS — Genetic Signatures Share News
0.000.00%
- AU$14.99m
- -AU$14.32m
- AU$21.36m
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement
Brief: Genetic Signatures Says Restructuring Expected To Result In Up To 30 Redundancies
Brief: Genetic Signatures Posts HY Statutory Revenue Of A$8.7 Million
Australia's Genetic Signature hits record low on lower quarterly sales
Brief: Genetic Signatures Logs Q2 Sales Of A$3.3 Million
Brief: Genetic Signatures Says CEO Allison Rossiter To Leave
Brief: Genetic Signatures Announces Resignation Of CFO Karl Pechmann
Australia's Genetic Signatures set for best day on sales growth
Brief: Genetic Signatures Says Quarterly Sales Reach A$5.4 Million
Brief: Genetic Signatures Posts Loss For Year Attributable A$20.1 Million
Brief: Genetic Signatures Announces Strategic Partnership With Tecan And Repado
Brief: Genetic Signatures Reports Quarterly Sales Of A$4.4 Million
Brief: Genetic Signatures Logs Loss For Half-Year Attributable A$15.2 Mln
Brief: Genetic Signatures Posts Qtrly Sales Of A$4.7 Mln
Australian pharma firm Genetic Signatures gains as Bell Potter lifts PT
Australia's Genetic Signatures jumps on US FDA nod for diagnosis kit